| Summary: | 碩士 === 國立中山大學 === 生物科學系研究所 === 99 === m-3M3FBS is a new compound that has been used as a phospholipase C (PLC)
activator. The effect of m-3M3FBS on cytosolic free Ca2+ concentrations in human
gastric cancer cells (SCM1) is unclear. This study explored whether m-3M3FBS
changed basal [Ca2+]i levels in suspended SCM1 cells by using fura-2 as a
Ca2+-sensitive fluorescent dye. m-3M3FBS at concentrations between 1-50 μM
increased [Ca2+]i in a concentration-dependent manner. The Ca2+ signal was reduced
partly by removing extracellular Ca2+. This Ca2+ influx was inhibited by phospholiapase
A2 inhibitor aristolochic acid , store-operated Ca2+ channel blockers nifedipine 、
econazole and SK&F96365; and protein kinase C inhibitor GF109203X. Phorbol
12-myristate 13-acetate ([PMA] a protein kinase C activator) had no effect on
m-3M3FBS-induced [Ca2+]i rise. In Ca2+-free medium , pretreatment with m-3M3FBS
abolished thapsigargin (TG) or 2,5-di-tert-butylhydroquinone (BHQ) - induced [Ca2+]i
rise. Conversely, pretreatment with the endoplasmic reticulum Ca2+ pump inhibitors TG
or BHQ partly inhibited m-3M3FBS -induced Ca2+ release. The inhibition of PLC with
U73122 did not alter mMIRC. Collectively, in SCM1 cells, mMIRC by causing PLCindependent
Ca2+ release from the endoplasmic reticulum and Ca2+ influx via
phospholipase A2-protein kinase C-sensitive store-operated Ca2+ channels.
|
|---|
